As 2026 gets under way, it might be a good time to highlight some of our 2025 success stories.
These will be somewhat generic explanations as nearly all of these are covered with Non-Disclosure Agreements.
-
- Two of our 2025 economics projects resulted in research publication early this year. (See separate announcements for these.)
- We provided cost analytics that along with clinical explanations that enabled Medicare to make changes to certain payment policies. As the result, more patients potentially will have access to life-savings treatments.
- We worked with another company to help them better understand patient demographics and economics for a rare disease. This work helps paint a broader understanding of treatment options and disease progression. Not only did the research result in a poster for a major conference, the poster won an award for presentation.
- We helped another company verify and understand mortality and economic costs of certain types of surgeries. This economics understanding should go a long ways toward helping patient outcomes as well as controlling hospital costs.
- We helped a number of early stage start-up companies better understand the economics of their new devices or treatments. We were able to assist them in better understanding their pathway to patient care and marketplace acceptance.
- It was a busy year, and 2026 proves to be equally as fruitful.